Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 22:13:929854.
doi: 10.3389/fphar.2022.929854. eCollection 2022.

Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform

Fengzhi Cui  1 , Jianhua Liu  1 , Siwen Pang  1 , Bo Li  1
Affiliations
Review

Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform

Fengzhi Cui et al. Front Pharmacol. .

Abstract

The tumor microenvironment (TME) plays an important role in the development, progression, and metastasis of cancer, and the extremely crucial feature is hypoxic and acidic. Cancer-associated fibroblasts (CAFs), extracellular matrix (ECM), mesenchymal cells, blood vessels, and interstitial fluid are widely recognized as fundamentally crucial hallmarks for TME. As nanotechnology briskly boomed, the nanoscale drug delivery and imaging platform (NDDIP) emerged and has attracted intensive attention. Based on main characteristics of TME, NDDIP can be classified into pH-sensitive delivery and imaging platforms, enzyme-sensitive delivery and imaging platforms, thermo-sensitive delivery and imaging platforms, redox-sensitive delivery and imaging platforms, and light-sensitive delivery and imaging platforms. Furthermore, imageology is one of the significant procedures for disease detection, image-guided drug delivery, and efficacy assessment, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound (US), and fluorescence imaging. Therefore, the stimuli-responsive NDDIP will be a versatile and practicable tumor disease diagnostic procedure and efficacy evaluation tool. In this review article, we mainly introduce the characteristics of TME and summarize the progress of multitudinous NDDIP as well as their applications.

Keywords: TME; cancer therapy; imaging platform; nanomaterials; stimuli-responsive nanoscale drug delivery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Graphical summarization of five different types of stimuli put into the design of stimuli-sensitive nanocarriers for drug delivery and imaging platforms: pH-sensitive delivery and imaging platforms, enzyme-sensitive delivery and imaging platforms, thermo-sensitive delivery and imaging platforms, redox-sensitive delivery and imaging platforms, and light-sensitive delivery and imaging platforms.
FIGURE 2
FIGURE 2
| Malignant tumor cells are characterized by intracellular high concentrations of GSH. Advantage is taken from this in developing the redox-responsive drug delivery platform. Sun and colleagues explore redox-sensitive delivery platform (mPEG-ss-Tripp). Synthesized mPEG-ss-Tripp was loaded with doxorubicin via a disulfide bond, which is sensitive to reductive substance GSH and then quickly cleaved through thiol-disulfide exchange, in order to release the DOX at targeted sites without damaging normal tissues (Sun et al., 2021).
See this image and copyright information in PMC

References

    1. Aminu N., Bello I., Umar N. M., Tanko N., Aminu A., Audu M. M. (2020). The Influence of Nanoparticulate Drug Delivery Systems in Drug Therapy. J. Drug Deliv. Sci. Technol. 60, 101961. [J]. 10.1016/j.jddst.2020.101961 - DOI
    1. Anderson N. M., Simon M. C. (2020). The Tumor Microenvironment. Curr. Biol. 30 (16), R921–R925. 10.1016/j.cub.2020.06.081 - DOI - PMC - PubMed
    1. Bai M., Yang M., Gong J., Xu H., Wei Z. (2021). Progress and Principle of Drug Nanocrystals for Tumor Targeted Delivery. AAPS PharmSciTech 23 (1), 41. 10.1208/s12249-021-02200-w - DOI - PubMed
    1. Barati Bagherabad M., Afzaljavan F., Shahidsales S., Hassanian S. M., Avan A. (2017). Targeted Therapies in Pancreatic Cancer: Promises and Failures. J. Cell Biochem. 120, 2726–2741. [J]. 10.1002/jcb.26284 - DOI - PubMed
    1. Bharathiraja S., Manivasagan P., Santha Moorthy M., Bui N. Q., Jang B., Phan T. T. V., et al. (2018). Photo-based PDT/PTT Dual Model Killing and Imaging of Cancer Cells Using Phycocyanin-Polypyrrole Nanoparticles. Eur. J. Pharm. Biopharm. 123, 20–30. 10.1016/j.ejpb.2017.11.007 - DOI - PubMed